Immutep Limited
Status: Publicly traded
Direct answer
Immutep Limited is publicly traded on NASDAQ under the ticker IMMP.
Immutep Limited is a biotechnology enterprise focused on the exploration and advancement of medicinal candidates. The company specializes in creating immunotherapeutic solutions for treating both cancerous conditions and autoimmune disorders. Its primary investigational drug is eftilagimod alpha (referred to as efti or IMP321), a recombinant protein currently in a Phase IIb clinical trial, being assessed as a...
Can you invest in Immutep Limited?
Yes. Immutep Limited is publicly traded on NASDAQ under the ticker IMMP.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Immutep Limited
Detailed equity research is provided by MarketSnap.